Canada markets open in 3 hours 26 minutes

Ocular Therapeutix, Inc. (0OT.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
4.6260+0.1340 (+2.98%)
As of 09:03AM CEST. Market open.
Currency in EUR

Valuation Measures4

Market Cap (intraday) 726.32M
Enterprise Value 621.41M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)7.05
Price/Book (mrq)8.17
Enterprise Value/Revenue 10.63
Enterprise Value/EBITDA -9.36

Trading Information

Stock Price History

Beta (5Y Monthly) 1.32
52-Week Change 3-18.70%
S&P500 52-Week Change 323.57%
52 Week High 310.8100
52 Week Low 31.8800
50-Day Moving Average 37.7584
200-Day Moving Average 34.4967

Share Statistics

Avg Vol (3 month) 3929
Avg Vol (10 day) 3601
Shares Outstanding 5154.73M
Implied Shares Outstanding 6162.44M
Float 8129.23M
% Held by Insiders 10.92%
% Held by Institutions 157.09%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -138.15%
Operating Margin (ttm)-135.46%

Management Effectiveness

Return on Assets (ttm)-25.66%
Return on Equity (ttm)-127.64%

Income Statement

Revenue (ttm)58.44M
Revenue Per Share (ttm)0.73
Quarterly Revenue Growth (yoy)5.20%
Gross Profit (ttm)N/A
EBITDA -79.4M
Net Income Avi to Common (ttm)-80.74M
Diluted EPS (ttm)-0.9500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)195.81M
Total Cash Per Share (mrq)1.32
Total Debt (mrq)83.39M
Total Debt/Equity (mrq)91.50%
Current Ratio (mrq)6.66
Book Value Per Share (mrq)0.79

Cash Flow Statement

Operating Cash Flow (ttm)-70.23M
Levered Free Cash Flow (ttm)-49.44M